278 related articles for article (PubMed ID: 20590706)
1. The French polidocanol study on long-term side effects: a survey covering 3,357 patient years.
Guex JJ; Schliephake DE; Otto J; Mako S; Allaert FA
Dermatol Surg; 2010 Jun; 36 Suppl 2():993-1003. PubMed ID: 20590706
[TBL] [Abstract][Full Text] [Related]
2. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
3. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
Rabe E; Pannier F
Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
[TBL] [Abstract][Full Text] [Related]
4. Stroke after varicose vein foam injection sclerotherapy.
Forlee MV; Grouden M; Moore DJ; Shanik G
J Vasc Surg; 2006 Jan; 43(1):162-4. PubMed ID: 16414404
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy.
Schuller-Petrović S; Pavlović MD; Neuhold N; Brunner F; Wölkart G
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):983-6. PubMed ID: 21740464
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up.
Ouvry P; Allaert FA; Desnos P; Hamel-Desnos C
Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):366-70. PubMed ID: 18524643
[TBL] [Abstract][Full Text] [Related]
7. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA
Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971
[TBL] [Abstract][Full Text] [Related]
8. Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam.
Reich-Schupke S; Weyer K; Altmeyer P; Stücker M
Vasa; 2010 May; 39(2):169-74. PubMed ID: 20464673
[TBL] [Abstract][Full Text] [Related]
9. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.
Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB
Trials; 2014 Dec; 15():497. PubMed ID: 25527165
[TBL] [Abstract][Full Text] [Related]
10. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
Tessari L; Cavezzi A; Frullini A
Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
[TBL] [Abstract][Full Text] [Related]
11. Foam sclerotherapy for spouting haemorrhage in patients with varicose veins.
Hamahata A; Yamaki T; Osada A; Fujisawa D; Sakurai H
Eur J Vasc Endovasc Surg; 2011 Jun; 41(6):856-8. PubMed ID: 21420881
[TBL] [Abstract][Full Text] [Related]
12. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.
Frullini A; Cavezzi A
Dermatol Surg; 2002 Jan; 28(1):11-5. PubMed ID: 11991262
[TBL] [Abstract][Full Text] [Related]
13. Foam sclerotherapy combined with surgical treatment for recurrent varicose veins: short term results.
Creton D; Uhl JF
Eur J Vasc Endovasc Surg; 2007 May; 33(5):619-24. PubMed ID: 17224284
[TBL] [Abstract][Full Text] [Related]
14. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
Willenberg T; Smith PC; Shepherd A; Davies AH
Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
[TBL] [Abstract][Full Text] [Related]
15. Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects.
Palm MD; Guiha IC; Goldman MP
Dermatol Surg; 2010 Jun; 36 Suppl 2():1026-33. PubMed ID: 20590709
[TBL] [Abstract][Full Text] [Related]
16. Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review.
Bossart S; Daneluzzi C; Cazzaniga S; Ramelet AA; Uthoff H; Seyed Jafari SM; Baumgartner M; Hunger RE; Heidemeyer K; Willenberg T
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):274-283. PubMed ID: 36196455
[TBL] [Abstract][Full Text] [Related]
17. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias.
Goldman PM
J Dermatol Surg Oncol; 1989 Feb; 15(2):204-9. PubMed ID: 2644330
[TBL] [Abstract][Full Text] [Related]
18. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial.
Gonzalez Ochoa AJ; Carrillo J; Manríquez D; Manrique F; Vazquez AN
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):154-162. PubMed ID: 32739509
[TBL] [Abstract][Full Text] [Related]
19. Sclerotherapy in an undetected pregnancy - a catastrophe?
Reich-Schupke S; Leiste A; Moritz R; Altmeyer P; Stücker M
Vasa; 2012 Jul; 41(4):243-7. PubMed ID: 22825857
[TBL] [Abstract][Full Text] [Related]
20. Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol.
Künzlberger B; Pieck C; Altmeyer P; Stücker M
Dermatol Surg; 2006 Nov; 32(11):1410-3. PubMed ID: 17083597
[No Abstract] [Full Text] [Related]
[Next] [New Search]
